Versor Investments’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-7,831
Closed -$821K – 728
2024
Q3
$821K Buy
7,831
+5,806
+287% +$679K 0.13% 257
2024
Q2
$288K Buy
2,025
+218
+12% +$25.1K 0.05% 537
2024
Q1
$202K Sell
1,807
-8,139
-82% -$970K 0.04% 615
2023
Q4
$1.29M Buy
9,946
+2,381
+31% +$328K 0.26% 76
2023
Q3
$1.23M Buy
7,565
+3,309
+78% +$582K 0.25% 84
2023
Q2
$780K Sell
4,256
-2,063
-33% -$297K 0.14% 131
2023
Q1
$842K Buy
6,319
+3,281
+108% +$385K 0.11% 163
2022
Q4
$241K Buy
+3,038
New +$214K 0.02% 588
2022
Q3
– Sell
-13,551
Closed -$743K – 773
2022
Q2
$743K Buy
13,551
+6,831
+102% +$396K 0.03% 353
2022
Q1
$508K Buy
6,720
+3,520
+110% +$240K 0.02% 327
2021
Q4
$239K Buy
+3,200
New +$190K 0.01% 460

Other funds holding ACLS

Versor Investments's ACLS Position: Q4 2024 in Review

Versor Investments sold out of Axcelis (ACLS) in Q4 2024, closing a stake of 7,831 shares — an estimated $821K sold.

Versor Investments first reported a position in ACLS in Q4 2021 and held it in 11 quarters. The position peaked at $1.29M in Q4 2023. 325 funds tracked by Wall St. Rank hold ACLS as of Q4 2024.

  • Versor Investments reported no remaining Axcelis position as of Q4 2024 after selling out during the quarter.
  • Versor Investments sold 7,831 Axcelis shares in Q4 2024, an estimated $821K.
  • Versor Investments first reported a position in Axcelis in Q4 2021 and held it in 11 quarters.
  • Versor Investments's Axcelis position peaked at $1.29M in Q4 2023.
  • 325 funds tracked by Wall St. Rank held Axcelis as of Q4 2024.

Based on Versor Investments's 13F filing for Q4 2024, filed 5 Feb 2025.